Participants who receive genetic testing results can follow up with their choice of health system or provider. Credit: Billion Photos/Shutterstock.com.

St Luke’s University Health Network has collaborated with Helix on a population genomics research programme which aims to enrol 100,000 participants from Pennsylvania and New Jersey initially.

Expected to extend over the next four years, the programme will provide valuable insights about precision medicine.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Upon confirmation of participant’s consent, Helix will apply its end-to-end genomics platform and unique Sequence Once, Query Often model to run genomic tests without the need for collection of an additional sample.

Participants will receive important health information about their potential risks for serious health conditions such as cancer and cardiovascular disease.

This helps them consult with their healthcare provider to prevent or delay these conditions from occurring in future.

See Also:

Hereditary conditions including familial hypercholesterolemia, Lynch syndrome and hereditary breast and ovarian cancer (BRCA1 and BRCA2) often go unrecognised.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Participants who receive genetic testing results can also follow up with their choice of health system or provider.

Helix CEO and co-founder Dr James Lu said: “Our partnership with St Luke’s gives providers and patients access to vital genetic information that can impact not only their lives but their entire families, for generations to come.

“We’re delighted to partner with St Luke’s and other leading health systems deploying genomics at scale across the US.”

HealthPartners, the Medical University of South Carolina, Memorial Hermann and WellSpan Health are Helix’s group of partner health systems participating in the research.